The impact of diabetes and metabolic syndromes to the effectiveness of cyclosporine a pharmacotherapy in psoriatic patients-Reference-Cited by-同舟云学术

The impact of diabetes and metabolic syndromes to the effectiveness of cyclosporine a pharmacotherapy in psoriatic patients

Published:2019-04-16 Issue:3 Volume:32 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Michalska‐Bańkowska Anna¹,Grabarek Beniamin²,Wcisło‐Dziadecka Dominika³^ORCID,Gola Joanna²

Affiliation:

1. Department of DermatologySchool of Medicine in Katowice, Medical University of Silesia Sosnowiec Poland

2. Department of Molecular BiologySchool of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia Sosnowiec Poland

3. Department of CosmetologySchool of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia Sosnowiec Poland

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.12881

Reference11 articles.

1. Cyclosporine in clinical practice: A retrospective study comparing fixed dose and body weight‐based dose regimens in psoriatic patients;Bardazzi F.;Giornale italiano di dermatologia e venereologia,2018

2. The use of cyclosporine in dermatology;Dehesa L.;Journal of Drugs in Dermatology,2012

3. Weight loss improves the response of obese patients with moderate‐to‐severe chronic plaque psoriasis to low‐dose cyclosporine therapy: A randomized, controlled, investigator‐blinded clinical trial;Gisondi P.;The American Journal of Clinical Nutrition,2008

4. Psoriasis and the metabolic syndrome

5. High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing the Patient with Psoriasis and Metabolic Comorbidities;American Journal of Clinical Dermatology;2024-05-15

2. Nonalcoholic Fatty Liver Disease and Psoriasis;Essentials of Non-Alcoholic Fatty Liver Disease;2023

3. The Impact of Hypertension, Diabetes, Lipid Disorders, Overweight/Obesity and Nicotine Dependence on Health-Related Quality of Life and Psoriasis Severity in Psoriatic Patients Receiving Systemic Conventional and Biological Treatment;International Journal of Environmental Research and Public Health;2021-12-14

4. Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies;Psoriasis: Targets and Therapy;2021-12

5. Skin and metabolic syndrome: A review of the possible associations;Journal of Research in Medical Sciences;2021